Certara, Inc.

NASDAQ:CERT

10.95 (USD) • At close September 13, 2024
Bedrijfsnaam Certara, Inc.
Symbool CERT
Munteenheid USD
Prijs 10.95
Beurswaarde 1,761,734,550
Dividendpercentage 0%
52-weken bereik 10.5 - 19.87
Industrie Health Information Services
Sector Healthcare
CEO Dr. William F. Feehery Ph.D.
Website https://www.certara.com

An error occurred while fetching data.

Over Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide

Vergelijkbare Aandelen

GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc.

GDRX

7.75 USD

Progyny, Inc. logo

Progyny, Inc.

PGNY

24.15 USD

Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc.

VIR

8.11 USD

Patterson Companies, Inc. logo

Patterson Companies, Inc.

PDCO

21.87 USD

Neogen Corporation logo

Neogen Corporation

NEOG

16.13 USD

Karuna Therapeutics, Inc. logo

Karuna Therapeutics, Inc.

KRTX

329.83 USD

Telesis Bio, Inc. logo

Telesis Bio, Inc.

TBIO

1.6 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)